Abstract
Chronic hepatitis B (CHB) belongs to chronic inflammatory disease. It is primarily transmitted through blood, mother to child, and sexual contact. In clinical practice, it is necessary to improve the examination as soon as possible. Only by early treatment can people delay and control the development of the disease and stabilize the disease. Otherwise, it will cause cirrhosis and lead to complications, such as ascites, bleeding, liver cancer, and so on. Antiviral therapy is the first choice for chronic hepatitis B virus infection. There are many drugs related to antiviral treatment in clinics, and different drugs have different effects. Vaccination can reduce the occurrence of diseases to a certain extent. However, despite hepatitis B having very effective vaccinations and excellent vaccinations available, there are still lots of patients that with the chronic hepatitis B in the sub-Saharan Africa. Due to the low HBV birth rate and limited resources in the sub-Saharan Africa, an effective and trustworthy strategy need to be built to achieve the goal of HBV elimination in sub-Saharan Africa. This article analyzes the current situation of prevention of the hepatitis B in the sub-Saharan region, and puts forward some intervention and prevention measures in order to provide some theoretical basis for the prevention and treatment of hepatitis B.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call